Although both STIM1 and STIM2 sense calcium release, leading to influx of extracellular calcium [49–51], our results demonstrate that gain or loss of STIM1 alone has minimal effect on EMT, whereas gain or loss of STIM2 has a substantial impact on EMT in breast cancer cells. The gene discussed is STIM2; the disease is breast carcinoma.